South Africa


KPMG’s Pharmaceuticals team is dedicated to assisting businesses of all sizes from biotechnology start-ups to large multinational pharmaceutical companies.

Gavin Maile

Gavin Maile

Clients and Sectors: Industrial, Automotive & Pharmaceutical

+27 (0)11 647 7165

Consolidation among the major players is expected globally as mergers, acquisitions and strategic alliances continue across the pharmaceutical and biotechnology sectors, driven by escalating R&D costs, blockbuster drug patent expirations and a need to bolster R&D pipelines. With such high R&D costs, patent and intellectual property protection will remain an ongoing issue for the industry. Protection of patents is one of the most important determinants of the long-term prosperity of research-orientated pharmaceutical companies.

How we can help

KPMG’s Pharmaceutical industry practice advises clients with critical business and industry issues, including:


  • Enterprise risk management
  • Research and development tax concessions and grants
  • Sales force and marketing compliance
  • Intellectual property and contract governance
  • Transfer pricing
  • Assurance and audit services
  • Cross-border financing and tax planning
  • Mergers, acquisitions and asset disposal
  • Market entry and expansion
  • Fraud risk management
  • Supply chain optimisation.


KPMG’s Pharmaceuticals industry advisers bring high-level technical capabilities and deep industry experience to every engagement. They are supported by KPMG’s global resources, collaborative knowledge-sharing systems and industry insight programmes.